Higher oxidative stress linked to metabolic syndrome

December 22, 2016

(HealthDay)—Oxidized low-density lipoprotein (ox-LDL) as a proxy for oxidative stress is associated with metabolic syndrome (MetS) and its components, according to a study published online Dec. 19 in Diabetes.

Yamilee Hurtado-Roca, M.D., from the Centro Nacional de Investigaciones Cardiovasculares Carlos III in Madrid, and colleagues examined the correlation between and MetS using data from 3,987 subjects without diabetes in the Progression of Early Subclinical Atherosclerosis study.

The researchers found that after adjustment for age, sex, smoking, LDL cholesterol, , waist circumference, and homeostatic model assessment of (HOMA-IR), the odds ratios for MetS for the second, third, and fourth quartiles of ox-LDL versus the first quartile were 0.84 (95 percent confidence interval, 0.52 to 1.36), 1.47 (95 percent confidence interval, 0.95 to 2.32), and 2.57 (95 percent confidence interval, 1.66 to 4.04) (P < 0.001 for trend). For all MetS components except glucose concentration, results showed the same trend. Overall, 13.9 percent of the association between waist circumference and triglycerides was mediated by ox-LDL, as was 1 to 3 percent of the association between and high-density lipoprotein cholesterol, blood pressure, and insulin resistance. The correlation between ox-LDL and MetS components was not mediated by HOMA-IR.

"Ox-LDL may reflect core mechanisms through which MetS components develop and progress in parallel with insulin resistance and could be a clinically relevant predictor of MetS development," the authors write.

Explore further: Evolocumab safe, effective for those with dysglycemia, MetS

More information: Full Text (subscription or payment may be required)

Related Stories

Evolocumab safe, effective for those with dysglycemia, MetS

September 16, 2016

(HealthDay)—For patients with or without dysglycemia or metabolic syndrome (MetS), evolocumab is safe and efficacious for reducing low-density lipoprotein cholesterol at 52 weeks, according to research published online ...

Socioeconomic status in children tied to MetS in adulthood

October 28, 2016

(HealthDay)—Family socioeconomic status (SES) in childhood is associated with the risk for metabolic syndrome (MetS) and glucose abnormalities in adulthood, according to a study published online Oct. 18 in Diabetes Care.

Metabolic syndrome linked to arterial stiffness in CKD

June 4, 2012

(HealthDay) -- For patients with chronic kidney disease (CKD), those with metabolic syndrome (MetS) have increased arterial stiffness but no increase in endothelial dysfunction, compared to those without MetS, according to ...

Recommended for you

Designing better drugs to treat type 2 diabetes

May 18, 2017

Research led by the University of Adelaide is paving the way for safer and more effective drugs to treat type 2 diabetes, reducing side effects and the need for insulin injections.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.